South Africa’s first cannabis clinical trial examining the plant’s effectiveness as an alternative to opioids for chronic pain management looks to enrol 300 participants
Cannabis has been shown to reduce inflammation and assist in rebuilding connections within the brain (neuroplasticity) that were damaged via concussion or during recovery.
Medical cannabis is associated with a number of favorable outcomes for patients with rheumatic diseases, including a lessened symptom burden and discontinuation of opioids or sleeping pills.